RxDoctor Payments Data

Augusto Pichard

Interventional Cardiology · Washington, DCNPI 1669422960

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $108,141 of the $180,168 with a category attached, or 60.0%. Abbott accounts for 99.2% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2022 at $81,324 and has fallen 100.0% since, to $14 in 2025.

$180,168in general payments, 2019–2025

Across 173 payments — averaging $1041.43 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$179K
  • GE HealthCare$994
  • Medtronic$406
  • Boston Scientific$112
$1,745in research payments, 2019–2025

Across 2 payments — averaging $872.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$2K

What the payments were for

  • Consulting fees$108,14160%
  • Speaking & faculty fees$30,44317%
  • Grants$4060%
  • Travel & lodging$39,60022%
  • Food & beverage$1,5771%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott165$178,655
GE HealthCare6$994
Medtronic1$406
Boston Scientific1$112

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few interventional cardiology providers in District of Columbiato place this figure against a meaningful peer group, so we don't.

Other interventional cardiology in Washington

See the full list for District of Columbia →

Where these figures come from

Is this you, or does something look wrong? →